Bionano to Present at the 2023 Stifel Healthcare Conference

Rhea-AI Summary

Bionano Genomics, Inc. (Nasdaq: BNGO) announced that its CEO, Erik Holmlin, will present at the 2023 Stifel Healthcare Conference on November 15. The presentation will be available through a webcast and a recording will be accessible on the company's website for at least 30 days.

SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at 2023 Stifel Healthcare Conference on November 15, 2023.

Conference & Webcast Details

Date:	Wednesday, November 15th, 2023
Time:	1:50 p.m. to 2:20 p.m. ET
Presenter:	Erik Holmlin, PhD, CEO of Bionano
Webcast:	Link to Register

A replay / recording of the session will be available following the conference through the Bionano website at https://ir.bionano.com/ for at least 30 days.

About Bionano

Bionano is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software. The Company offers OGM solutions for applications across basic, translational and clinical research. Through its Lineagen, Inc. d/b/a Bionano Laboratories business, the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. The Company also offers an industry-leading, platform-agnostic software solution, which integrates next-generation sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. For more information, visit www.bionano.com, www.bionanolaboratories.com or www.purigenbio.com.

Unless specifically noted otherwise, Bionano’s OGM products are for research use only and not for use in diagnostic procedures.

CONTACTS

Company Contact:
Erik Holmlin, CEO
Bionano Genomics, Inc.
+1 (858) 888-7610
eholmlin@bionano.com

Investor Relations:
David Holmes
Gilmartin Group
+1 (858) 888-7625
IR@bionano.com

FAQ

What is the news about Bionano Genomics, Inc.?

Bionano Genomics, Inc. announced that its CEO, Erik Holmlin, will present at the 2023 Stifel Healthcare Conference.

When will the presentation take place?

The presentation will take place on November 15, 2023.

Where can I access the webcast?

The webcast can be accessed through the company's website.

Will there be a recording of the session available?

Yes, a recording of the session will be available on the company's website for at least 30 days.